GlassScriptPhysician profile
Trechelle Monique Carson
NPI 1891181780
$4,519.50
in general payments reported to CMS, 2019-2025
25 companies · $512 in 2025
The $512 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $55.01 · 2022: $151 · 2023: $135 · 2024: $3,465 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,619 · Education: $1,500 · Food and Beverage: $994.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,618.70 |
| Education | $1,500.00 |
| Food and Beverage | $993.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,239.55 | 2024 | |
| Abbvie INC. | $202.98 | 2019-2025 | |
| Novo Nordisk INC | $185.13 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Sumitomo Pharma America, INC. | $153.25 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $106.88 | 2024-2025 | Veozah |
| Coopersurgical, INC. | $70.98 | 2022-2024 | Wallach Cryosurgical Equipment, Paragard T 380a |
| Exact Sciences Corporation | $64.82 | 2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $57.83 | 2022-2025 | |
| Organon LLC | $53.16 | 2022-2025 | Nexplanon |
| Pfizer INC. | $45.84 | 2022-2025 | |
| Smith+Nephew, INC. | $42.68 | 2022-2025 | Pico 14 |
| Abbott Laboratories | $40.66 | 2025 | Freestyle Libre 3 |
| Optumhealth Care Solutions, LLC | $25.20 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Aspira Women'S Health INC | $24.70 | 2022 | |
| Hologic Sales and Service, LLC | $23.82 | 2023 | Myosure Tissue Removal Device |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.43 | 2024 | Jardiance |
| Duchesnay USA Incorporated | $22.87 | 2019 | |
| Millicent US INC | $22.47 | 2020 | |
| Mayne Pharma Commercial LLC | $20.23 | 2022 | |
| Biogen, INC. | $18.42 | 2025 | Zurzuvae |
| Pacira Pharmaceuticals Incorporated | $17.01 | 2020 | |
| Therapeuticsmd, INC. | $15.53 | 2020 | |
| Minerva Surgical, INC | $14.38 | 2023 | |
| Exeltis, USA INC. | $13.99 | 2024 | Slynd |
| Provepharm INC. | $13.69 | 2025 | Bludigo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trechelle Carson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.